<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04026347</url>
  </required_header>
  <id_info>
    <org_study_id>CD1010</org_study_id>
    <nct_id>NCT04026347</nct_id>
  </id_info>
  <brief_title>Vesair Clinical Trial</brief_title>
  <acronym>VAPOR</acronym>
  <official_title>An Evaluation of the VesairÂ® Bladder Control System for the Treatment of Stress Urinary Incontinence in Post-Menopausal Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Solace Therapeutics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Solace Therapeutics, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single-blind, multicenter, randomized clinical trial of the Vesair Balloon in the treatment
      of Stress Urinary Incontinence in post-menopausal women
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Subject and assessor blinded to randomization result</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Composite Endpoint</measure>
    <time_frame>6 months</time_frame>
    <description>Pad weight + I-QOL</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pad Weight</measure>
    <time_frame>6 months</time_frame>
    <description>Reduction in pad weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>I-QOL</measure>
    <time_frame>6 months</time_frame>
    <description>Improvement in I-QOL score (0-100 point scale, 100 being the best outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Episode Frequency</measure>
    <time_frame>6 months</time_frame>
    <description>Reduction in episode frequency as reported on a 7 day diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Improvement (PGI-I)</measure>
    <time_frame>6 months</time_frame>
    <description>Significant Improvement per PGI-I (response of very much better or much better on 7 point scale)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Stress Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>Vesair</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects are treated with Vesair Balloon at enrollment (day 0)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Subjects are treated with sham at enrollment (day 0) and treated with balloon (if desired) after six month visit.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vesair Balloon</intervention_name>
    <description>Indwelling, intravesical balloon</description>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_label>Vesair</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham balloon placement</intervention_name>
    <description>Sham balloon placement procedure</description>
    <arm_group_label>Sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Post-menopausal women with SUI for at least 12 months

          -  Average of at least one leak per day

          -  Failed non-invasive treatment

          -  Willing to undergo cystoscopy and a minimum of 5 visits over one year

        Exclusion Criteria:

          -  BMI &gt; 40.0

          -  Last menstrual period within 12 months of enrollment

          -  On birth control and/or oral hormone replacement therapy

          -  Urge-predominant mixed incontinence

          -  SUI due to intrinsic sphincter deficiency

          -  Prior treatment with the Vesair Balloon

          -  Prior medical, surgical or non-surgical treatment for SUI within 6 months of
             enrollment

          -  Recurrent or recent (within the past 5 years) kidney stones

          -  Recurrent or recent (within the past 3 months) Urinary Tract Infection

          -  Stage 3 or higher cystocele (POP-Q)

          -  Interstitial or follicular cystitis / painful bladder syndrome

          -  Local genital infection

          -  Artificial sphincter

          -  Anatomic abnormalities which would interfere with device placement.

          -  Visible blood in the urine

          -  Uncontrolled bladder contractions / discomfort with bladder filling up to 300cc

          -  History of cancer of the urinary tract

          -  History of any cancer within the past two years (excluding non-melanoma skin cancers)

          -  History of any cancer not (yet) treated with curable intent (excluding non-melanoma
             skin cancers)

          -  Immunologically suppressed or immunocompromised

          -  Undergoing pelvic radiation, pelvic fibrosis from previous pelvic radiation

          -  Non ambulatory / unable to do simple pad weight testing exercises

          -  On anticoagulation therapy with the exception of aspirin

          -  History of mental illness requiring inpatient treatment

          -  Neurological disease such as Parkinson's or multiple sclerosis

          -  Uncontrolled diabetes (A1C &gt; 9%)

          -  Recent alcohol or drug abuse requiring treatment in the past year

          -  Autoimmune or connective tissue disorders such as Marfan syndrome, Ehlers-Danlos or
             Myasthenia Gravis

          -  Allergy to polyurethane or perfluorocarbons
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Joshua A Freeman</last_name>
    <phone>508-283-1200</phone>
    <phone_ext>168</phone_ext>
    <email>jfreeman@solacetx.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nicole Shugrue</last_name>
    <phone>508-283-1200</phone>
    <phone_ext>165</phone_ext>
    <email>nschugrue@solacetx.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Valley Urogynecology Associates</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Downer</last_name>
      <phone>602-788-1521</phone>
      <email>adowner@valleyurogyn.com</email>
    </contact>
    <investigator>
      <last_name>Shazia Malik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Felipe Videla, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul Marshburn, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Stone, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Scripps Clinic</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Tri Valley Urology</name>
      <address>
        <city>Temecula</city>
        <state>California</state>
        <zip>92592</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anita Deeds</last_name>
      <phone>951-698-1901</phone>
      <phone_ext>232</phone_ext>
      <email>anita@trivalleyurology.com</email>
    </contact>
    <investigator>
      <last_name>Benjamin T. Larson, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Women's Health Specialty Care</name>
      <address>
        <city>Farmington</city>
        <state>Connecticut</state>
        <zip>06032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Madeline Vazquez</last_name>
      <phone>860-678-7300</phone>
      <phone_ext>5</phone_ext>
      <email>mvazquez@womenshealthct.com</email>
    </contact>
    <investigator>
      <last_name>Jill Peters-Gee, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adine Regan, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Urology Partners</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33615</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Seibert, M.S.</last_name>
      <phone>239-223-4488</phone>
      <email>linda@gulfcoastcta.com</email>
    </contact>
    <investigator>
      <last_name>Osvaldo Padron, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>WomanCare</name>
      <address>
        <city>Arlington Heights</city>
        <state>Illinois</state>
        <zip>60004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Umbright</last_name>
      <phone>847-221-4241</phone>
      <email>vumbrigh@womancarepc.com</email>
    </contact>
    <investigator>
      <last_name>Randall Kahan, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Regional Urology</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leah Renfro</last_name>
      <phone>318-683-0411</phone>
      <phone_ext>125</phone_ext>
      <email>lrenfro@regionalresearchspecialists.com</email>
    </contact>
    <investigator>
      <last_name>Kevin Cline, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Allison Spann, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ashley Baker, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chesapeake Urology</name>
      <address>
        <city>Hanover</city>
        <state>Maryland</state>
        <zip>21076</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy Paxton</last_name>
      <phone>443-471-5763</phone>
      <email>wpaxton@chesuro.com</email>
    </contact>
    <investigator>
      <last_name>Kaiser Robertson, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chesapeake Urology</name>
      <address>
        <city>Owings Mills</city>
        <state>Maryland</state>
        <zip>21117</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Mercy Health</name>
      <address>
        <city>Ada</city>
        <state>Michigan</state>
        <zip>49301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julie Bishop, RN</last_name>
      <phone>616-685-4691</phone>
      <email>Julie.A.Bishop@mercyhealth.com</email>
    </contact>
    <investigator>
      <last_name>Jason Bennett, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Freedman Urology</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89144</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Medina</last_name>
      <phone>702-675-3102</phone>
      <email>josemedina@freedmanurology.com</email>
    </contact>
    <investigator>
      <last_name>Sheldon Freedman, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Premier Medical Group of the Hudson Valley</name>
      <address>
        <city>Poughkeepsie</city>
        <state>New York</state>
        <zip>12601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Gray</last_name>
      <phone>845-437-3804</phone>
      <email>lgray@premiermedicalhv.com</email>
    </contact>
    <investigator>
      <last_name>Daniel Katz, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Associated Urologists of North Carolina</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlene Flahiff, MS</last_name>
      <phone>919-390-7352</phone>
      <email>cflahiff@auncurology.com</email>
    </contact>
    <contact_backup>
      <last_name>Glenna Gourley</last_name>
      <phone>919.390.7354</phone>
      <email>ggourley@auncurology.com</email>
    </contact_backup>
    <investigator>
      <last_name>Mark Jalkut, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penn Medicine</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19041</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zandra Kennedy</last_name>
      <phone>215-615-6569</phone>
      <email>zandra.kennedy@pennmedicine.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Lily Arya, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Uduak Andy, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Heidi Harvie, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Women and Infants dept of Urogynecology</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Veera, B.S.</last_name>
      <phone>401-274-1122</phone>
      <phone_ext>48222</phone_ext>
      <email>sveera@wihri.org</email>
    </contact>
    <investigator>
      <last_name>Charles Rardin, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Urology of Virginia</name>
      <address>
        <city>Virginia Beach</city>
        <state>Virginia</state>
        <zip>23462</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leigh Ann Brand</last_name>
      <phone>757-452-3421</phone>
      <email>lbrand@urologyofva.net</email>
    </contact>
    <investigator>
      <last_name>Kurt McCammon, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jennifer Miles-Thomas, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jessica DeLong, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington Urology</name>
      <address>
        <city>Kirkland</city>
        <state>Washington</state>
        <zip>98034</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kayla Lee, LPN</last_name>
      <phone>425-398-9355</phone>
      <email>KLee@WaUrology.com</email>
    </contact>
    <investigator>
      <last_name>Karny Jacoby, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.solacetx.com</url>
    <description>Company Website</description>
  </link>
  <link>
    <url>http://www.laughwithoutleaks.com</url>
    <description>Study Website</description>
  </link>
  <results_reference>
    <citation>McCammon K, Jacoby K, Kalota S, Snyder J, Cline K, Robertson K, Rardin C, Kahan R, Green L, Zuckerman J, Rovner E. Three-month primary efficacy data for the SUCCESS Trial; a phase III, multi-center, prospective, randomized, controlled study treating female stress urinary incontinence with the vesair intravesical balloon. Neurourol Urodyn. 2018 Jan;37(1):440-448. doi: 10.1002/nau.23324. Epub 2017 Nov 2.</citation>
    <PMID>29095516</PMID>
  </results_reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>July 17, 2019</study_first_submitted>
  <study_first_submitted_qc>July 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2019</study_first_posted>
  <last_update_submitted>May 28, 2020</last_update_submitted>
  <last_update_submitted_qc>May 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SUI</keyword>
  <keyword>Women</keyword>
  <keyword>Incontinence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

